Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue ▴	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
PPCB	Propanc Biopharma, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$18.86M	n/a	-200.6%	n/a	-$17.62
PTIX	Protagenic Therapeutics, Inc.\new Manufacturing · Year ended 2026-03-31 · USD	n/a	$1.37M	n/a	52.2%	n/a	$0.59
PTPI	Petros Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.91M	n/a	66.7%	n/a	-$1.56
PULM	Pulmatrix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.16M	n/a	-135.5%	n/a	-$1.41
PVLA	Palvella Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$41.72M	n/a	-149.1%	n/a	-$3.71
QNRX	Quoin Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.80M	n/a	-120.5%	n/a	n/a
RAPP	Rapport Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$111.48M	n/a	-23.0%	n/a	-$2.86
REVB	Revelation Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.91M	n/a	-100.6%	n/a	-$23.95
RIGL	Rigel Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	$367.02M	n/a	93.8%	n/a	$19.48
RKTO	Rocket One Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.47M	n/a	-202.7%	n/a	-$0.90
RLMD	Relmada Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$57.39M	n/a	-66.3%	n/a	-$1.45
RNAZ	Transcode Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$34.66M	n/a	-335.4%	n/a	-$52.59
RVPH	Reviva Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.86M	n/a	-229.7%	n/a	n/a
RVRC	Revium Rx. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.45M	n/a	-195.5%	n/a	-$0.22
RZLT	Rezolute, Inc. Manufacturing · Year ended 2026-06-30 · USD	n/a	-$77.59M	n/a	-77.1%	n/a	-$0.75
SGMT	Sagimet Biosciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$51.04M	n/a	-45.8%	n/a	-$1.58
SHPH	Shuttle Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.72M	n/a	-519.9%	n/a	-$7.16
SION	Sionna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.27M	n/a	-24.5%	n/a	-$1.88
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41
SLS	SELLAS Life Sciences Group, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.86M	n/a	-37.9%	n/a	-$0.25
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
SMNR	Semnur Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$160.42M	n/a	n/a	n/a	-$0.78
SNGX	Soligenix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.08M	n/a	-209.4%	n/a	-$2.14
SVRA	Savara Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$118.84M	n/a	-58.5%	n/a	-$0.53
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33

Rows per page: 2550 100